Home › Kanser sa Pantog › Missouri

Pag-aaral pangklinika para sa Kanser sa Pantog sa Missouri

26 pag-aaral para sa Kanser sa Pantog ang naghahanap ng mga kalahok sa mga site sa Missouri.

Mga Lungsod sa Missouri

Opisyal na teksto ng pag-aaral (English)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Saint Francis Medical Center, Cape Girardeau
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
Siteman Cancer Center at West County Hospital, Creve Coeur
at 11 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03866382

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Saint Francis Medical Center, Cape Girardeau
Parkland Health Center - Farmington, Farmington
Lake Regional Hospital, Osage Beach
at 5 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06770582

The Vanguard Study: Testing a New Way to Screen for Cancer

Saint Luke's Hospital of Kansas City, Kansas City
CoxHealth South Hospital, Springfield
Washington University School of Medicine, St Louis

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06995898

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Washington University School of Medicine in St. Louis, St Louis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
Central Care Cancer Center - Bolivar, Bolivar
Cox Cancer Center Branson, Branson
at 21 pa

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Washington University in St. Louis, St Louis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05614739

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Saint Francis Medical Center, Cape Girardeau

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07061964

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Missouri Cancer Associates, Columbia
Siteman Cancer Center, St Louis

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07566156

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Washington University, School of Medicine, St Louis

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06172478

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Central Care Cancer Center - Bolivar, Bolivar
Mercy Cancer Center - Cape Girardeau, Cape Girardeau
Saint Francis Medical Center, Cape Girardeau
at 18 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07097142

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Siteman Cancer Center - St. Peters, City of Saint Peters
Siteman Cancer Center - West County, Creve Coeur
Siteman Cancer Center - North County, Florissant
at 4 pa

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT07421700

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Oncology Hematology Associates, Springfield
Washington University School of Medicine, St Louis

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT07218380

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Renown Regional Medical Center, St Louis

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT07480356

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

University of Missouri Health Care ( Site 0126), Columbia

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06833073

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Washington University School of Medicine, St Louis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06529822

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Washington University, St Louis

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05267626

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Specialty Clinical Research of St. Louis, St Louis

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06567743

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Renown Regional Medical Center, St Louis
Specialty Clinic Research of St. Louis, St Louis

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05951179

IDOV-Immune for Advanced Solid Tumors

Washington University School of Medicine, St Louis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06910657

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Mosaic Life Care at Saint Joseph - Medical Center, Saint Joseph

Nagre-recruitPhase 2

Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Research Site, Kansas City

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07720284

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Mercy Hospital - SPG, Springfield
Mercy Hospital - South, St Louis
Mercy Hospital -STL, St Louis

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07327489

Integrated Cancer Repository for Cancer Research

Saint Luke's Cancer Institute, East, Kansas City
Saint Luke's Cancer Institute, Kansas City
Saint Luke's Cancer Institute, Kansas City North, Kansas City
at 3 pa

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

Washington University, St Louis

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT05982561

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Washington University, St Louis

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 18, 2026 · NCT07030257

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Kansas City
Massive Bio SYNERGY-AI site, St Louis

Nagre-recruitObservasyonal na pag-aaral

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.